|

Hetrombopag Clinical Trials

4 actively recruiting trials

Pipeline

Phase 2: 3

Top Sponsors

  • Henan Cancer Hospital1
  • Fudan University1
  • Changhai Hospital1
  • Beijing Children's Hospital1

Indications

  • Cancer4
  • Chemotherapy-induced Thrombocytopenia (CIT) in Patients With Gastrointestinal Tumors1
  • Liver Disease1
  • Autologous Hematopoietic Stem Cell Transplantation1
  • Delayed Platelet Engraftment1

Other4 trials

A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Anti-tumor Treatment in Advanced Breast Cancer
Phase 2
Efficacy and Safety of Herombopag in Patients With Thrombocytopenia Before Hepatectomy
Phase 2
Efficacy and Safety of Hetrombopag in Preventing Chemotherapy-induced Thrombocytopenia in Gastrointestinal Tumors
Phase 2
Hetrombopag in Promoting Platelet Engraftment After Auto-HSCT in Children With Neuroblastoma
N/A

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.